Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.
Latest from Ryan Nelson
The co-founder of Pure Global discusses the regulatory consultancy's use of AI to support clients’ marketing submissions and other needs, as well as the AI-enabled medtech landscape and opportunities in China and Southeast Asia for accessing patient data for AI development purposes.
Deloitte Center for Health Solutions surveyed 85 leaders from medtech organizations for its report, “Is Generative AI changing the game for medtech?” Respondents replied overwhelmingly “yes,” while acknowledging the industry thus far has only scratched the surface of AI’s potential.
Plaintiffs in California federal courts seek restitution, damages, and other relief on behalf of themselves and consumers nationwide, whom allegedly were deceived by “Plant-Based” representations on Aveeno and Neutrogena Makeup Removing Wipes.
Predetermined change control plans have potential to accelerate US FDA review timelines for device modifications, but visibility remains low as to whether the program is behaving as advertised and delivering efficiencies sought by sponsors. Joshua Oyster, partner in Ropes & Gray’s Washington, D.C. office, offers perspective.
The RAC opinion begins the process of prohibiting use of talc in cosmetic products marketed in the EU. A consultation period will follow the Commission’s preparation of a delegated act.
Coty will leverage insights and feedback from its Scientific Advisory Board, which met for the first time on 24 September in Monaco, to drive skin-care innovation. Dermatologist-founded brand SEEN, at the intersection of luxury hair care and skin care, has $9m in new funding. More beauty news in brief.